EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation

Na Zhao, Rong Chi iD, Kaidi Song, Yue Wu, Bingbing Yan, Dongyao Wang iD, Baolin Tang, Xiaoyu Zhu iD

Blood and Lymphatic Cancer: Targets and Therapy · 2026-05 · Volume 16 · 1-16

DOI: 10.2147/blctt.s582933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2026-05. Verfasst von Na Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Chin…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

competing risksimmune recoveryprognosisstratification

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
  • State Key Laboratory of Immune Response and Immunotherapy, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
  • Anhui Provincial Key Laboratory of Blood Research and Applications, Hefei, Anhui, People's Republic of China.
  • Blood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.

ORCID-Profile: Rong Chi, Dongyao Wang, Xiaoyu Zhu

Zitieren

APA

Zhao, N., Chi, R., Song, K., Wu, Y., Yan, B., Wang, D., Tang, B., & Zhu, X. (2026). A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation. Blood and Lymphatic Cancer: Targets and Therapy, Volume 16, 1-16. https://doi.org/10.2147/blctt.s582933

Vancouver

Zhao N, Chi R, Song K, Wu Y, Yan B, Wang D, et al. A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation. Blood and Lymphatic Cancer: Targets and Therapy. 2026;Volume 16:1-16. doi:10.2147/blctt.s582933

BibTeX
@article{Zhao2026,
  author = {Zhao, Na and Chi, Rong and Song, Kaidi and Wu, Yue and Yan, Bingbing and Wang, Dongyao and Tang, Baolin and Zhu, Xiaoyu},
  title = {A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation},
  journal = {Blood and Lymphatic Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 16},
  pages = {1--16},
  doi = {10.2147/blctt.s582933}
}
Kostenlos starten →